NCT00395720View on ClinicalTrials.gov

The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

TuberculosisHIV Infections

Interventions

BIOLOGICAL

MVA85A (TB vaccine)

Intradermal vaccine

BIOLOGICAL

MVA 85A

Intradermal vaccine

Trial Locations (1)

OX3 7LJ

Centre for Clinical Vaccinology and Tropical Medicine, Oxford

All Listed Sponsors

lead

University of Oxford

OTHER

NCT00395720 - The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV | Biotech Hunter | Biotech Hunter